Home › Post-COVID Conditions (Long COVID) › NCT04834869
COVID-19 Vaccines Safety Tracking (CoVaST)
COVID-19 Vaccines Safety Tracking: Global Consortium Study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * HCW, OA and ST who received COVID-19 vaccine. * Participating subjects should be at least 18-year-old and able to give their informed consent independently. Exclusion Criteria: * Non HCW, OA and ST who received the COVID-19.
About the study
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
What is being tested
- BNT162b2 (biological)
- mRNA-1273 (biological)
- AZD1222 (biological)
- CoronaVac (biological)
- Sinopharm (biological)
- Gam-COVID-Vac (biological)
Sponsor: Masaryk University · Participants: 30,000 · Started: Apr 1, 2021
Contact the study team
- Miloslav Klugar, PhD · Phone: +420549495676
- Abanoub Riad, DDS · Phone: +420549496572
Official record on ClinicalTrials.gov — NCT04834869
Locations in the U.S.
| Pennsylvania | American College of Physicians, Philadelphia (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.